<< Read Full Article
<< Read Full Article
Last Thursday, Celgene(CELG Quote), the last of six biotech bellwethers to report third-quarter results, closed out what proved to be a strong period for the sector.
Biotech stocks have no doubt suffered along with the rest of the market, but for the group, from an earnings standpoint at least, it seems to be business as usual.
Gilead(GILD Quote), Biogen Idec(BIIB Quote) and Amgen(AMGN Quote) delivered notable profit beats, while most of the six had better-than-expected sales. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,328.89 | 1,102.47 | 2,211.69 | 35.46 |
Oil *
73.88
|
|
UP
20.63
|
UP
6.40
|
UP
31.64
|
UP
0.59
|
10 Yr
3.55%
SPDR Gold
108.95
|
|
+0.20%
|
+0.58%
|
+1.45%
|
+1.69%
|
Data delayed 20 minutes |
Connect with TheStreet